þ | ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
A. | Full title of the plan and address of the plan, if different from that of the issuer named below: |
B. | Name of issuer of the securities held pursuant to the plan and the address of its principal executive office: |
Page | ||
1 | ||
Financial Statements: |
||
2 | ||
3 | ||
4 | ||
Supplemental Schedule*: |
||
10 | ||
11 | ||
12 |
* | All other schedules required by the Department of Labor Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974 have been omitted because they are not applicable. |
1
2008 | 2007 | |||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 11,405 | $ | 29,621 | ||||
Investments |
||||||||
Investments, at fair value |
| 530,248 | ||||||
Loans to participants |
| 10,480 | ||||||
Total investments |
11,405 | 570,349 | ||||||
Liabilities |
||||||||
Miscellaneous payables |
5,830 | 5,759 | ||||||
Total liabilities |
5,830 | 5,759 | ||||||
Net assets available for benefits |
$ | 5,575 | $ | 564,590 | ||||
2
2008 | 2007 | |||||||
Additions to net assets |
||||||||
Investment (losses) income |
||||||||
Interest and dividend income |
$ | 5,769 | $ | 50,289 | ||||
Net (depreciation) appreciation in fair value of investments |
(35,975 | ) | 131,293 | |||||
Net investment (losses) income |
(30,206 | ) | 181,582 | |||||
Contributions |
||||||||
Company |
| 22,999 | ||||||
Participant |
| 50,934 | ||||||
Other |
| 25,905 | ||||||
Total contributions |
| 99,838 | ||||||
Total (decrease) increase to additions to net assets |
(30,206 | ) | 281,420 | |||||
Deductions from net assets |
||||||||
Benefits paid to participants |
(527,309 | ) | (3,326,915 | ) | ||||
Administrative expenses |
(1,500 | ) | | |||||
Total deductions from net assets |
(528,809 | ) | (3,326,915 | ) | ||||
Net decrease to net assets |
(559,015 | ) | (3,045,495 | ) | ||||
Net assets available for benefits |
||||||||
Beginning of year |
564,590 | 3,610,085 | ||||||
End of year |
$ | 5,575 | $ | 564,590 | ||||
3
1. | Description of Plan | |
The following description of the Watson Laboratories Caribe, Inc., 1165(e) Plan (the Plan) provides only general information. Participants should refer to the Plan agreement for a more complete description of the Plans provisions. Through August 28, 2000, Danbury Pharmacal Puerto Rico, Inc. was an indirectly owned subsidiary of Schein Pharmaceutical, Inc. On August 28, 2000, Watson Pharmaceuticals, Inc. (the Company) acquired all of the outstanding stock of Schein Pharmaceutical, Inc. | ||
In October 2005, the Company announced the planned closure of the Puerto Rico facility during 2007. Effective June 30, 2006, a group of employees at the Puerto Rico site were laid off with subsequent layoffs occurring through 2007 until the final layoff on March 30, 2007. The Employee Benefit Plans Committee of the Plan (the Plans Committee) approved the termination of the Plan concurrent with the Puerto Rico site closure effective March 30, 2007, and on October 2, 2007 filed for a final favorable determination letter with the Puerto Rico Treasury Department. The Puerto Rico Treasury Department issued a final favorable determination letter on March 17, 2008. The Plan balance decreased significantly as a result of these events. The remaining net assets will be distributed to participants in a lump-sum payment or rollover as soon as administratively practicable. | ||
General | ||
The Plan is a defined contribution plan subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA) and is administered by the Plans Committee. Eligible employees are those employees of Watson Laboratories Caribe, Inc. (formerly Danbury Pharmacal Puerto Rico, Inc.) at the date of hire. | ||
The Plan and related trust are designed to operate under Section 1165(a), (e) and (g) of the Puerto Rico Income Tax Act of 1954. Under the Internal Revenue Code (IRC), participants are not liable for federal income taxes on employee contributions, Company contributions, or Plan earnings thereon until such time as they are partially or completely withdrawn from the Plan. | ||
Vesting | ||
Participant contributions and related earnings are fully vested immediately. Participants hired on or after January 1, 2004 vest in Company contributions at a rate of 33 1/3% each year until fully vested after three years. Participants hired prior to January 1, 2004 are immediately vested in Company contributions. In accordance with the Plan agreement, benefits attributable to each participant become fully vested in all accounts in the event of death, disability, normal retirement age of 65, or the complete or partial termination of the Plan. Accordingly, with the approval of the termination of the Plan concurrent with the Puerto Rico site closure effective March 30, 2007, all benefits attributable to each participant became fully vested effective March 30, 2007. | ||
Contributions | ||
Participants may elect to contribute from 1% to 10% of their total eligible compensation to the Plan, subject to a maximum dollar limitation as defined by the IRC. Participants may also make rollover contributions from other qualified plans. | ||
The Company contributes 50% of the first 8% of total eligible compensation that a participant contributes to the Plan. In addition to these matching contributions, the Company may elect to |
4
make discretionary profit sharing contributions. The Company did not make any discretionary profit sharing contributions during the years ended December 31, 2008 and 2007. | ||
Participant Accounts | ||
Each participants account is credited with (a) participant contributions, (b) Company matching contributions, (c) discretionary profit-sharing contributions, if any, and (d) an allocation of Plan earnings or losses thereon to the participants account in the same proportion as the participants beginning account balance invested in the fund (as defined in the Plan) in relation to the total fund balance. Loan interest is credited to the investment funds of the participant making the payment. The benefit to which a participant is entitled is the benefit that can be provided from the participants vested account. Participants direct the investment of their accounts. Changes to these investment elections are allowed at anytime. | ||
Investment Options | ||
The investment fund options for the years ended December 31, 2008 and 2007 consist of various mutual funds and a Company stock fund, which are generally described below: | ||
Ariel Appreciation Fund | ||
The fund invests primarily in the stocks of medium-sized companies with market capitalization generally between $2.5 billion and $15 billion. The fund seeks socially responsible, undervalued companies. | ||
Columbia Small Cap Fund | ||
The fund invests primarily in stocks of companies that have market capitalization similar in size to those in the Russell 2000 Index. | ||
Federated Government Obligations | ||
The fund invests in U.S. Treasurys government agency securities and repurchase agreements backed by government securities. | ||
Federated Kaufman Fund | ||
The fund invests principally in stocks of companies that are reasonably priced and exhibit positive growth. | ||
Franklin Templeton Foreign Fund | ||
The fund seeks long-term capital growth by investing at least 80% of its assets in securities of companies outside the United States. | ||
Lord Abbett Mid-Cap Fund | ||
The fund seeks long-term capital appreciation by investing in stocks of medium-sized companies believed to be undervalued in the marketplace. | ||
Allianz OCC Value Fund | ||
The fund invests in securities within the large-cap arena that are trading at a significant discount to their intrinsic value based on their current financial situation and future prospects. | ||
PIMCO Total Return Fund Administrative Class (PIMCO Fund) | ||
The fund invests in corporate bonds, U.S. government bonds and money market instruments. |
5
T. Rowe Price Growth Stock Fund | ||
The fund invests at least 80% of assets in the common stocks of a diversified group of growth companies. | ||
Watson Pharmaceuticals Company Stock Fund
(Company Stock Fund) Through August 28, 2000, Plan participants could elect to contribute up to 10% of their contributions in the Company Stock Fund. This fund invested in common stock of Schein Pharmaceutical, Inc. Effective August 28, 2000, all common stock of Schein Pharmaceutical, Inc. was converted into common stock of Watson Pharmaceuticals, Inc. and thereafter, contributions in the Company Stock Fund have been invested in the common stock of Watson Pharmaceuticals, Inc. |
||
Participant Loans | ||
Participants may borrow a minimum of $250 and a maximum equal to the lesser of $50,000 or 50% of the participants vested account balance. Each loan is collateralized by the participants vested account balance and bears interest commensurate with local prevailing rates as determined by the Plans Administration Committee. Repayment of principal and interest is provided by uniform payroll deductions over a period of up to five years for all loans unless loan proceeds were used to purchase a primary residence. The maximum repayment period for loans used to purchase a primary residence is determined by reference to bank loans for the same purpose. | ||
Payment of Benefits | ||
Upon termination of employment, benefits are paid in the form of an annuity, periodic payments over a period of no more than ten years or a lump-sum amount equal to the value of the participants vested interest in his or her account. Certain participants, pursuant to the qualifications set forth in the Plan agreement, may elect to have his or her vested interest transferred to an Individual Retirement Account or another employer qualified plan. Withdrawals are also permitted for financial hardship, which is determined pursuant to the provisions of the IRC, and for a participants vested account balance after age 59 1/2. | ||
Forfeitures | ||
Nonvested Company contributions are forfeited upon termination of employment. These amounts are allocated to each participants accounts based upon the relation of the participants compensation to total compensation for the Plan year. In May 2007, the Plan allocated forfeitures in the amount of $77,400 to the account of each participant and former participant(provided they still had an account balance in the Plan). As of December 31, 2008 and 2007, there were no unallocated forfeitures in the Plan. | ||
Administrative Expenses | ||
The Company has historically paid all administrative expenses on behalf of the Plan. Such expenses amounted to $4,400 and $36,300 for the years ended December 31, 2008 and 2007, respectively. In addition, during 2008, the Plan paid $1,500 in administrative expenses from amounts due by the Plan to the Company. | ||
Plan Termination | ||
The Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan, subject to the provisions of ERISA. In the event of Plan termination, participants become 100% vested in their accounts and the net assets of the Plan will be allocated among the participants or their beneficiaries, after payment of any expenses properly chargeable to |
6
the Plan, in accordance with the provisions of ERISA. The Plans Committee approved the termination of the Plan concurrent with the March 30, 2007 Puerto Rico site closure. Refer to Note 5. Tax Status for additional information related to the termination of the Plan. | ||
2. | Summary of Significant Accounting Policies | |
Basis of Accounting | ||
The financial statements of the Plan have been prepared on the liquidation basis of accounting in conformity with accounting principles generally accepted in the United States of America (GAAP). Refer to Note 1. Description of Plan and Note 5. Tax Status for additional information related to the termination of the Plan. | ||
Use of Estimates | ||
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of additions and deductions to net assets in the statement of changes in net assets available for benefits during the reporting period. Actual results could differ from those estimates. | ||
Risks and Uncertainties | ||
The Plan provides for various investment options in any combination of investment securities. Investment securities are exposed to various risks, including interest rate risk, market risk and credit risk. Due to the level of risk associated with certain investment securities and the level of uncertainty related to changes in the value of investment securities, it is at least reasonably possible that changes in risks in the near term would materially affect participants account balances and the amounts reported in the statements of net assets available for benefits and the statement of changes in net assets available for benefits. | ||
Investment Valuation and Income Recognition | ||
The Plans investments are stated at fair value which approximates liquidation value. If available, quoted market prices are used to value investments. | ||
Shares of registered investment company funds are valued at the net asset value of shares held by the Plan at year end. Shares of common stock are valued at quoted market prices. Loans to participants are valued at their outstanding balances, which approximates fair value. | ||
Purchases and sales of securities are recorded on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. | ||
The net appreciation in fair value of investments consists of both the realized gains or losses and unrealized appreciation and depreciation of those investments. | ||
Payment of Benefits | ||
Payments to participants are recorded when paid. |
7
3. | Investments | |
The following presents investments that represent 5% or more of the Plans net assets at December 31,: |
2008 | 2007 | |||||||
BPPR Time deposit Open Account |
$ | 11,405 | $ | 29,620 | ||||
Federated Government Obligations |
* | 230,691 | ||||||
Allianz Occ Value Fund |
* | 102,570 | ||||||
PIMCO Total Return Fund Administrative Class |
* | 74,670 | ||||||
Federated Kaufman Fund |
* | 65,937 | ||||||
Franklin Templeton Foregin Fund |
* | 29,231 |
* | Investment was less than 5% of the Plans net assets at year-end. |
For the years ended December 31, 2008 and 2007, the Plans investments (including realized gains and losses on investments bought and sold and unrealized appreciation and depreciation on investments held during the year) (decreased) increased in fair value as follows: |
2008 | 2007 | |||||||
Mutual Fund |
$ | (36,685 | ) | $ | 132,411 | |||
Company common stock |
710 | (1,118 | ) | |||||
Net (depreciation) appreciation in fair value of investments |
$ | (35,975 | ) | $ | 131,293 | |||
4. | Party-In-Interest-Transactions | |
Plan assets include investments in funds managed by Trust Division of Banco Popular de Puerto Rico, is a wholly-owned subsidiary of Popular, Inc. Banco Popular de Puerto Rico is the Plans trustee and custodian, and, therefore, these transactions qualify as party-in-interest transactions. | ||
The Plan held Company common stock with fair values of $0 and $13,000 at December 31, 2008 and 2007, respectively. At December 31, 2008 and 2007, 0 and 479 shares of common stock are included in the Company Stock Fund, respectively. The Plan made purchases and sales of the Company Stock Fund during 2007 and sales during 2008. | ||
5. | Tax Status | |
The Plan has adopted the Banco Popular de Puerto Rico master plan agreement which has been previously determined to be in accordance with the applicable requirements of the IRC. | ||
The Employee Benefit Plans Committee approved the termination of the Plan concurrent with the Puerto Rico site closure effective March 30, 2007, and on October 2, 2007 filed for a final favorable determination letter with the Puerto Rico Treasury Department. The Puerto Rico Treasury Department issued a final favorable determination letter on March 17, 2008. The net |
8
assets will be distributed to participants in a lump-sum payment or rollover as soon as administratively practicable. | ||
6. | Settlement from Pilgrim Baxter & Associates, Ltd. | |
The settlement of a short-term trading lawsuit filed by the Securities and Exchange Commission against Pilgrim Baxter & Associates, Ltd. for transactions in PBHG mutual funds conducted from June 1998 through December 2001 resulted in a restitution payment to the Plan of $21,346 on September 12, 2007. The payment was allocated in 2008 on a pro-rated basis to applicable plan participants. |
9
(b) Identity of issuer, | (c) Description of investment including | |||||||||||||||
borrower, lessor or similar | maturity date, rate of interest, | (e) Current | ||||||||||||||
(a) | party | collateral, par or maturity value | (d) Cost | Value | ||||||||||||
Time deposit and interest bearing cash: | ||||||||||||||||
* | Banco Popular de Puerto Rico |
BPPR Time Deposit Open Account | $ | 11,405 | ||||||||||||
$ | 11,405 | |||||||||||||||
* | Party-in-interest for which a statutory exemption exists. |
10
Watson Laboratories Caribe, Inc., 1165 (e) Plan | ||||||
By: | WATSON PHARMACEUTICALS, INC. as plan administrator | |||||
By: | /s/ Clare Carmichael
|
|||||
Chairperson, Employee Benefit Plans Committee |
11